News from KPMG
News from The Lawyer
Briefings from KPMG
As spending on pharmaceutical R&D continues to soar, executives, shareholders and analysts alike are entitled to ask: what value are we getting for our investment?
One of the biggest economic challenges facing governments and developers around the world is how to meet the growing demand for infrastructure development.